Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

CJC-1295 + GHRP-2 Blend Dosage Protocol | PeptideDosages.com

CJC-1295 + GHRP-2 (10 mg Blend) Dosage Protocol CJC-1295 + GHRP-2 (10 mg Blend) Dosage Protocol CJC-1295 + GHRP-2 Dosage Chart The CJC-1295 + GHRP-2 peptide blend is dosed at 150 mcg–300 mcg daily via subcutaneous injection in educational protocols. A 10 mg bl

CJC-1295 + GHRP-2 (10 mg Blend) Dosage Protocol

CJC-1295 + GHRP-2 (10 mg Blend) Dosage Protocol

CJC-1295 + GHRP-2 Dosage Chart

The CJC-1295 + GHRP-2 peptide blend is dosed at 150 mcg–300 mcg daily via subcutaneous injection in educational protocols. A 10 mg blend reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only.

Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration (1 unit ≈ 33.3 mcg).

Typical daily range: 100–300 mcg once daily (gradual titration).

Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.

Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F) for long-term; after reconstitution, refrigerate and use within 2–4 weeks.

CJC-1295 is a long-acting GHRH analog that can elevate GH levels 2–10× baseline for approximately 6 days and increase IGF-1 by 1.5–3× for 9–11 days[1]. GHRP-2 is a ghrelin-mimetic secretagogue with a plasma half-life of ~30 minutes that triggers rapid GH pulses peaking within ~25 minutes of administration[3]. Combining these peptides leverages GHRP-2’s acute pulsatile release with CJC-1295’s sustained action. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Related research: For distinct compound, component, or formulation evidence and safety context, read What Is GHRP-2? Mechanism, Benefits, Risks, and Alternatives and CJC-1295 DAC Peptide: Benefits, Uses, Side Effects, Dosage, and Research. These links are comparisons only; the compounds and formulations should not be treated as interchangeable.

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Weeks 1–2

150 mcg (0.15 mg)

4.5 units (0.045 mL)

Weeks 3–12

300 mcg (0.30 mg)

9 units (0.09 mL)

Frequency: Tie timing to the research design. Human work supports acute synergistic GH release when GHRH and a growth hormone-releasing peptide are combined[6]. The cited study used controlled intravenous administration and does not define a bedtime subcutaneous schedule for this exact blend.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Advanced / Twice-Daily Approach (3 mL = ~3.33 mg/mL)

Some protocols split the daily dose into two administrations (morning upon waking, fasted; and evening before bed) to enhance GH pulsatility[1]. Ensure doses are at least 3–8 hours apart to avoid overlapping GH pulses.

100 mcg (0.10 mg)

3 units (0.03 mL)

200 mcg

300 mcg

For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration (once-daily schedule).

Peptide Vials (CJC-1295 + GHRP-2, 10 mg each):

8 weeks ≈ 2 vials

12 weeks ≈ 3 vials

16 weeks ≈ 4 vials

Insulin Syringes (U-100):

Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.

8 weeks (2 vials): 6 mL → 1 × 10 mL bottle

12 weeks (3 vials): 9 mL → 1 × 10 mL bottle

16 weeks (4 vials): 12 mL → 2 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

16 weeks: 224 swabs → recommend 3 × 100-count boxes

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

PROCEDURE

How to Get Retatrutide in 2026 (Legit Options & Safety Checklist)

Looking for where to buy retatrutide for research use? Here’s a supplier checklist (COAs, testing, reviews, red flags) plus the clinical-trial pathway for legitimate access. MyPeptideMatch.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.
STORAGE

The Criticality of Proper Handling and Storage

Even the purest peptide is only as good as its handling. This is a message our team at Real Peptides reiterates constantly to researchers. CJC-1295 for growth hormone release, like most peptides, is a delicate molecule. Improper reconstitution, storage, or transport can degrade its integrity, rendering it ineffective. We recommend using only sterile, high-quality Bacteriostatic Reconstitution Water (bac) and following strict aseptic techniques. Once reconstituted, peptides generally have a shorter shelf life and require refrigeration. For long-term storage, freezing lyophilized powder is typically best. Our packaging is designed to maintain the peptide's stability during transit, but the responsibility for proper storage immediately upon receipt falls to the researcher. We provide detailed guidelines with every order because we’re invested in your success. It’s not just about selling a product; it’s about ensuring that product performs optimally in your hands. We want your research on CJC-1295 for growth hormone release to be as productive and insightful as possible.
02

Question drills

Open a question for its connected answer.

01Frequently Asked Questions About CJC-1295 Fat Metabolism+

What is CJC-1295 and how does it relate to fat metabolism?CJC-1295 is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to release growth hormone, which in turn influences fat metabolism by promoting lipolysis (fat breakdown) and enhancing lean muscle mass, thereby increasing metabolic rate. Is there a difference between CJC-1295 with DAC and without DAC for fat metabolism research?Yes, CJC-1295 with DAC has a longer half-life, meaning it stays active for an extended period, leading to a more sustained release of growth hormone. This can be beneficial for research protocols studying long-term effects on fat metabolism, while the no-DAC version provides a shorter, more acute pulse. What are the primary mechanisms by which CJC-1295 influences fat breakdown?CJC-1295 primarily influences fat breakdown indirectly by stimulating growth hormone release. Growth hormone is inherently lipolytic, signaling fat cells to release stored triglycerides as fatty acids for energy. It also promotes muscle synthesis, which boosts the body's resting metabolic rate. Can CJC-1295 be combined with other peptides for enhanced fat metabolism studies?Absolutely, many researchers combine CJC-1295 with other compounds like Ipamorelin, AOD-9604, or Tesamorelin 10mg to achieve synergistic effects in fat metabolism research. These combinations can target different aspects of metabolic regulation for more comprehensive results. What role does muscle mass play in CJC-1295 fat metabolism?Increased muscle mass, a common outcome of sustained growth hormone release stimulated by CJC-1295, is critical for fat metabolism. More muscle tissue directly translates to a higher basal metabolic rate, meaning the body burns more calories at rest, aiding in fat loss and metabolic efficiency. How important is peptide purity for accurate CJC-1295 fat metabolism research?Peptide purity is paramount. Impure or inconsistent peptides can lead to unreliable data, skewed results, and wasted resources. At Real Peptides, our small-batch synthesis and exact amino-acid sequencing guarantee the high purity and consistency crucial for accurate and reproducible fat metabolism studies. What are the best practices for reconstituting CJC-1295 for research purposes?For best results, always reconstitute CJC-1295 using Bacteriostatic Reconstitution Water (bac) in a sterile environment. Gently swirl the vial to dissolve the peptide, avoiding vigorous shaking, which can degrade the molecule. Proper reconstitution maintains the peptide's integrity and efficacy. Are there specific monitoring tools recommended for studies on CJC-1295 fat metabolism?Yes, comprehensive monitoring is essential. Researchers typically use tools like DEXA scans for body composition analysis, lipid panels to assess cholesterol and triglyceride levels, and glucose metabolism markers to track changes in blood sugar regulation. These provide objective data on metabolic shifts. How does CJC-1295 compare to newer GLP-1 agonists like Orforglipron for fat metabolism?CJC-1295 primarily works through growth hormone pathways to enhance lipolysis and muscle mass. GLP-1 agonists, such as Orforglipron Tablets, primarily reduce appetite and improve glucose homeostasis. Both impact fat metabolism, but through distinct mechanisms, making them potentially complementary in certain research designs. What ethical considerations should be kept in mind when researching CJC-1295 fat metabolism?All research involving peptides, including CJC-1295, must strictly adhere to established ethical guidelines, institutional review board (IRB) protocols, and relevant regulatory frameworks. Responsible conduct of research, subject safety, and data integrity are always the highest priorities. Where can researchers find reliable, high-purity CJC-1295 for their studies?Researchers can find high-purity, research-grade CJC-1295 and other peptides at Real Peptides. We specialize in providing meticulously synthesized compounds with exact amino-acid sequencing, ensuring the quality and consistency necessary for rigorous scientific inquiry. Visit our website to learn more. Has there been an increase in research on CJC-1295 fat metabolism in 2026?Yes, our observations indicate a continued and growing interest in CJC-1295 fat metabolism research in 2026. The demand for high-quality peptides for metabolic studies remains strong as scientists seek innovative solutions for complex health challenges like obesity and metabolic syndrome. We're seeing more sophisticated protocols emerging. What are some long-term implications of understanding CJC-1295 fat metabolism?Understanding CJC-1295 fat metabolism could pave the way for novel therapeutic strategies for obesity, sarcopenia, and age-related metabolic decline. It could lead to more targeted interventions that promote healthy body composition and metabolic function, significantly improving quality of life. Does Real Peptides offer bundles related to fat metabolism research?Indeed, we do. Our specialized bundles, such as the Fat Loss & Metabolic Health Bundle, are curated to provide researchers with complementary peptides that work synergistically to investigate various aspects of fat metabolism and metabolic health more broadly. It's about providing comprehensive tools for complex research questions. What makes Real Peptides a trusted source for CJC-1295 for fat metabolism studies?Our unwavering commitment to quality. Every peptide, including CJC 1295 (no Dac), undergoes small-batch synthesis with exact amino-acid sequencing, guaranteeing unparalleled purity and consistency. This meticulous process ensures researchers receive reliable compounds for their critical CJC-1295 fat metabolism experiments, supporting reproducible and meaningful scientific discovery.

SOURCE / realpeptides.co ↗
02What If the Peptide Dissolves But Looks Slightly Cloudy?+

Discard it immediately and do not proceed with injection. Cloudiness indicates either particulate contamination (bacterial, fungal, or foreign matter) or incomplete dissolution caused by degraded protein aggregates. Authentic CJC-1295 produces a solution indistinguishable from sterile water when properly reconstituted. Any visible haze means the vial is compromised. Attempting to filter the solution does not solve the problem because molecular degradation cannot be reversed, and bacterial contamination may include endotoxins that pass through standard filters.

SOURCE / realpeptides.co ↗
03What If I'm Using a 0.3mL Syringe Instead of 1mL?+

Tick volume remains 0.01mL per unit on U-100 syringes regardless of barrel size. A 0.3mL syringe just has 30 total ticks instead of 100. If your dose is 100mcg at 1mg/mL concentration, you still draw 10 ticks. The 0.3mL syringe works fine for doses up to 300mcg at 1mg/mL or 150mcg at 2mg/mL. Beyond that, you'd exceed barrel capacity and need to switch to a larger syringe or dilute your concentration further. Smaller syringes improve visual precision for low-dose protocols but don't change the math.

SOURCE / realpeptides.co ↗
04What If the Lyophilised Powder Looks Clumped or Discoloured Before Reconstitution?+

Discard the vial without reconstituting. Lyophilised CJC-1295 should appear as a white to off-white fluffy cake. Yellow, brown, or grey discolouration indicates oxidative degradation during storage. Likely from moisture exposure or prolonged temperature excursions above −20°C. Clumping suggests the vial was exposed to humidity, which reintroduces water and destabilises peptide bonds. Reconstituting degraded powder yields a solution with unknown potency and potential aggregation products that can interfere with assay results.

SOURCE / realpeptides.co ↗
05What If Long-Term Safety Data Beyond 12 Weeks Doesn't Exist in Animal Models?+

It largely doesn't—most cjc-1295 animal research spans 8–12 weeks, occasionally extending to 16 weeks in primate models. Chronic effects (pituitary adenoma risk, joint degeneration, insulin resistance progression) require 6–12 month timelines to manifest, and no published study has run that duration in a controlled animal cohort. The implication: human use extending beyond 3–4 months operates outside the evidence base established by animal research. That doesn't mean it's unsafe—it means the long-term risk profile is inferred from exogenous GH studies, not directly tested with CJC-1295.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

The Evidence-Based Truth About CJC-1295 and Fat Loss

Here's the honest answer: CJC-1295 doesn't cause fat loss the way marketing implies. It amplifies growth hormone secretion, which shifts metabolism toward lipolysis. But lipolysis alone isn't fat loss. Fat loss requires oxidation of released fatty acids, and oxidation requires energy demand that exceeds intake. The peptide creates a metabolic environment where fat burning is favored, but the actual burning depends entirely on whether you're in a deficit. The clinical data supports this distinction clearly. Every trial showing meaningful fat loss from CJC-1295 included structured caloric restriction, increased training volume, or both. Studies without dietary control show elevated GH, elevated free fatty acids, and no change in body composition. The peptide isn't ineffective. It's conditional. It does exactly what its mechanism predicts: it makes fat available for oxidation. Whether that fat gets oxidized depends on variables the peptide doesn't control. For research applications, this makes CJC-1295 valuable in body recomposition protocols where the goal is preserving lean mass during deficit, not in ad libitum fat loss studies. The peptide's real strength is metabolic optimization during restriction. Reducing muscle catabolism, maintaining anabolic signaling, and improving the ratio of fat loss to lean mass loss. That's a meaningful outcome, but it's not the same as independent fat burning.

RESEARCH

Is there a risk of desensitization with CJC-1295 use in research?

While not common with appropriate protocols, excessive or prolonged high-dose administration in research could theoretically lead to GHRH receptor desensitization. This highlights the importance of adhering to precise, evidence-based research protocols.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

Comparison Table: Real vs. Fake CJC-1295 Indicators

Third-Party COA Recent, specific, 98%+ HPLC purity, MS verified Absent, outdated, generic, low purity, or fabricated Vendor Reputation Established, transparent, responsive, educat…